Obrindatamab is a Humanized Anti-B7-H3/CD3 Bispecific Antibody for Cancer Research
B7-H3 (CD276) is a T cell co-stimulator and co-suppressor molecule. Specifically, B7-H3 plays an important role in tumor cell apoptosis, proliferation, adhesion, angiogenesis, invasion, migration, and escape from immune surveillance.…